Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge.

Lehrer AT, Wong TS, Lieberman MM, Johns L, Medina L, Feldmann F, Feldmann H, Marzi A.

Vaccine. 2019 Jul 16. pii: S0264-410X(19)30797-2. doi: 10.1016/j.vaccine.2019.06.035. [Epub ahead of print]

PMID:
31324500
2.

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.

Menicucci AR, Jankeel A, Feldmann H, Marzi A, Messaoudi I.

MBio. 2019 May 28;10(3). pii: e00597-19. doi: 10.1128/mBio.00597-19.

3.

Multicenter experience with the Evolution RL mechanical sheath for lead extraction using a stepwise approach: Safety, effectiveness, and outcome.

Migliore F, Testolina M, Sagone A, Carretta D, Agricola T, Rovaris G, Piazzi E, Facchin D, De Lazzari M, Zorzi A, Melillo F, Cataldi C, Marzi A, Bottio T, Tarzia V, Gerosa G, Iliceto S, Bertaglia E, Mazzone P.

Pacing Clin Electrophysiol. 2019 Jul;42(7):989-997. doi: 10.1111/pace.13700. Epub 2019 May 2.

PMID:
30997679
4.

The Path of Cicely Saunders: The "Peculiar Beauty" of Palliative Care.

Miccinesi G, Caraceni A, Garetto F, Zaninetta G, Bertè R, Broglia CM, Farci B, Aprile PL, Luzzani M, Marzi AM, Mercadante S, Montanari L, Moroni M, Piazza E, Pittureri C, Tassinari D, Trentin L, Turriziani A, Zagonel V, Maltoni M.

J Palliat Care. 2019 Mar 14:825859719833659. doi: 10.1177/0825859719833659. [Epub ahead of print]

PMID:
30871411
5.

Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.

Marzi A, Menicucci AR, Engelmann F, Callison J, Horne EJ, Feldmann F, Jankeel A, Feldmann H, Messaoudi I.

Front Immunol. 2019 Jan 22;9:3071. doi: 10.3389/fimmu.2018.03071. eCollection 2018.

6.

Current Ebola Virus Vaccine Progress.

Marzi A, Mire CE.

BioDrugs. 2019 Feb;33(1):9-14. doi: 10.1007/s40259-018-0329-7. Review.

PMID:
30604389
7.

Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques.

Nicholas VV, Rosenke R, Feldmann F, Long D, Thomas T, Scott DP, Feldmann H, Marzi A.

J Infect Dis. 2018 Nov 22;218(suppl_5):S458-S465. doi: 10.1093/infdis/jiy456.

PMID:
30215737
8.

Ebola: Lessons on Vaccine Development.

Feldmann H, Feldmann F, Marzi A.

Annu Rev Microbiol. 2018 Sep 8;72:423-446. doi: 10.1146/annurev-micro-090817-062414. Review.

PMID:
30200851
9.

Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine.

Robinson HL, Marzi A.

Expert Rev Vaccines. 2018 Sep;17(9):769-771. doi: 10.1080/14760584.2018.1510775. Epub 2018 Aug 20. No abstract available.

PMID:
30092691
10.

Long-Range Polymerase Chain Reaction Method for Sequencing the Ebola Virus Genome From Ecological and Clinical Samples.

Seifert SN, Schulz JE, Matson MJ, Bushmaker T, Marzi A, Munster VJ.

J Infect Dis. 2018 Nov 22;218(suppl_5):S301-S304. doi: 10.1093/infdis/jiy290.

PMID:
30085166
11.

A VSV-based Zika virus vaccine protects mice from lethal challenge.

Emanuel J, Callison J, Dowd KA, Pierson TC, Feldmann H, Marzi A.

Sci Rep. 2018 Jul 23;8(1):11043. doi: 10.1038/s41598-018-29401-x.

12.

Single-Nucleotide Polymorphisms in Human NPC1 Influence Filovirus Entry Into Cells.

Kondoh T, Letko M, Munster VJ, Manzoor R, Maruyama J, Furuyama W, Miyamoto H, Shigeno A, Fujikura D, Takadate Y, Yoshida R, Igarashi M, Feldmann H, Marzi A, Takada A.

J Infect Dis. 2018 Nov 22;218(suppl_5):S397-S402. doi: 10.1093/infdis/jiy248.

PMID:
30010949
13.

A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus.

Anguiano-Zarate SS, Matchett WE, Nehete PN, Sastry JK, Marzi A, Barry MA.

J Infect Dis. 2018 Nov 5;218(12):1883-1889. doi: 10.1093/infdis/jiy411.

PMID:
29982595
14.

Suspected Exposure to Filoviruses Among People Contacting Wildlife in Southwestern Uganda.

Smiley Evans T, Tutaryebwa L, Gilardi KV, Barry PA, Marzi A, Eberhardt M, Ssebide B, Cranfield MR, Mugisha O, Mugisha E, Kellermann S, Mazet JAK, Johnson CK.

J Infect Dis. 2018 Nov 22;218(suppl_5):S277-S286. doi: 10.1093/infdis/jiy251.

15.

Monoclonal Antibody Cocktail Protects Hamsters From Lethal Marburg Virus Infection.

Marzi A, Haddock E, Kajihara M, Feldmann H, Takada A.

J Infect Dis. 2018 Nov 22;218(suppl_5):S662-S665. doi: 10.1093/infdis/jiy235.

PMID:
29889266
16.

Ebola Virus Infection in Commonly Used Laboratory Mouse Strains.

Haddock E, Feldmann H, Marzi A.

J Infect Dis. 2018 Nov 22;218(suppl_5):S453-S457. doi: 10.1093/infdis/jiy208.

PMID:
29878128
17.

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials.

Suder E, Furuyama W, Feldmann H, Marzi A, de Wit E.

Hum Vaccin Immunother. 2018;14(9):2107-2113. doi: 10.1080/21645515.2018.1473698. Epub 2018 Jun 18. Review.

18.

Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models.

Marzi A, Chadinah S, Haddock E, Feldmann F, Arndt N, Martellaro C, Scott DP, Hanley PW, Nyenswah TG, Sow S, Massaquoi M, Feldmann H.

Cell Rep. 2018 May 8;23(6):1806-1816. doi: 10.1016/j.celrep.2018.04.027.

19.

Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out Mice.

Marzi A, Emanuel J, Callison J, McNally KL, Arndt N, Chadinha S, Martellaro C, Rosenke R, Scott DP, Safronetz D, Whitehead SS, Best SM, Feldmann H.

Front Cell Infect Microbiol. 2018 Apr 11;8:117. doi: 10.3389/fcimb.2018.00117. eCollection 2018.

20.

Filoviruses: Ecology, Molecular Biology, and Evolution.

Emanuel J, Marzi A, Feldmann H.

Adv Virus Res. 2018;100:189-221. doi: 10.1016/bs.aivir.2017.12.002. Epub 2018 Feb 1. Review.

PMID:
29551136
21.

Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study.

Caraceni A, Speranza R, Spoldi E, Ambroset CS, Canestrari S, Marinari M, Marzi AM, Orsi L, Piva L, Rocchi M, Valenti D, Zeppetella G, Zucco F, Raimondi A, Matos LV, Brunelli C; Italian Society of Palliative Care Study Group on Palliative Sedation in Adult Cancer Patients.

J Pain Symptom Manage. 2018 Jul;56(1):33-43. doi: 10.1016/j.jpainsymman.2018.03.008. Epub 2018 Mar 13.

PMID:
29548893
22.

Late potentials abolition reduces ventricular tachycardia recurrence after ablation especially in higher-risk patients with a chronic total occlusion in an infarct-related artery.

Di Marco A, Oloriz Sanjuan T, Paglino G, Baratto F, Vergara P, Bisceglia C, Trevisi N, Sala S, Marzi A, Gulletta S, Cireddu M, Anguera I, Della Bella P.

J Cardiovasc Electrophysiol. 2018 Aug;29(8):1119-1124. doi: 10.1111/jce.13488. Epub 2018 Apr 10.

PMID:
29543365
23.

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge.

Domi A, Feldmann F, Basu R, McCurley N, Shifflett K, Emanuel J, Hellerstein MS, Guirakhoo F, Orlandi C, Flinko R, Lewis GK, Hanley PW, Feldmann H, Robinson HL, Marzi A.

Sci Rep. 2018 Jan 16;8(1):864. doi: 10.1038/s41598-017-19041-y.

24.

Translation and Testing of the Italian Version of FAMCARE-2: Measuring Family Caregivers' Satisfaction With Palliative Care.

D'Angelo D, Punziano AC, Mastroianni C, Marzi A, Latina R, Ghezzi V, Piredda M, De Marinis MG.

J Fam Nurs. 2017 May;23(2):252-272. doi: 10.1177/1074840717697538. Epub 2017 Mar 16.

PMID:
28795900
25.

Evaluation of Ebola Virus Countermeasures in Guinea Pigs.

Marzi A.

Methods Mol Biol. 2017;1628:283-291. doi: 10.1007/978-1-4939-7116-9_23.

26.

Ebola and Marburg virus vaccines.

Reynolds P, Marzi A.

Virus Genes. 2017 Aug;53(4):501-515. doi: 10.1007/s11262-017-1455-x. Epub 2017 Apr 26. Review.

PMID:
28447193
27.

Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection.

Menicucci AR, Sureshchandra S, Marzi A, Feldmann H, Messaoudi I.

Sci Rep. 2017 Apr 20;7(1):919. doi: 10.1038/s41598-017-01032-8.

28.

Safety and efficacy of the new bidirectional rotational Evolution® mechanical lead extraction sheath: results from a multicentre Italian registry.

Mazzone P, Migliore F, Bertaglia E, Facchin D, Daleffe E, Calzolari V, Crosato M, Melillo F, Peruzza F, Marzi A, Sora N, Della Bella P.

Europace. 2018 May 1;20(5):829-834. doi: 10.1093/europace/eux020.

PMID:
28339758
29.

Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.

Olejnik J, Forero A, Deflubé LR, Hume AJ, Manhart WA, Nishida A, Marzi A, Katze MG, Ebihara H, Rasmussen AL, Mühlberger E.

J Virol. 2017 May 12;91(11). pii: e00179-17. doi: 10.1128/JVI.00179-17. Print 2017 Jun 1.

30.

Closer than ever to an Ebola virus vaccine.

Banadyga L, Marzi A.

Expert Rev Vaccines. 2017 May;16(5):401-402. doi: 10.1080/14760584.2017.1309977. Epub 2017 Apr 3. No abstract available.

31.

Immunobiology of Ebola and Lassa virus infections.

Prescott JB, Marzi A, Safronetz D, Robertson SJ, Feldmann H, Best SM.

Nat Rev Immunol. 2017 Mar;17(3):195-207. doi: 10.1038/nri.2016.138. Epub 2017 Jan 23. Review.

PMID:
28111475
32.

Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection.

Furuyama W, Marzi A, Carmody AB, Maruyama J, Kuroda M, Miyamoto H, Nanbo A, Manzoor R, Yoshida R, Igarashi M, Feldmann H, Takada A.

PLoS Pathog. 2016 Dec 30;12(12):e1006139. doi: 10.1371/journal.ppat.1006139. eCollection 2016 Dec.

33.

A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.

Marzi A, Banadyga L, Haddock E, Thomas T, Shen K, Horne EJ, Scott DP, Feldmann H, Ebihara H.

Sci Rep. 2016 Dec 15;6:39214. doi: 10.1038/srep39214.

34.

Left atrial appendage closure: A single center experience and comparison of two contemporary devices.

Figini F, Mazzone P, Regazzoli D, Porata G, Ruparelia N, Giannini F, Stella S, Ancona F, Agricola E, Sora N, Marzi A, Aurelio A, Trevisi N, Della Bella P, Colombo A, Montorfano M.

Catheter Cardiovasc Interv. 2017 Mar 1;89(4):763-772. doi: 10.1002/ccd.26678. Epub 2016 Aug 27.

PMID:
27567013
35.

Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients.

Rosenke K, Adjemian J, Munster VJ, Marzi A, Falzarano D, Onyango CO, Ochieng M, Juma B, Fischer RJ, Prescott JB, Safronetz D, Omballa V, Owuor C, Hoenen T, Groseth A, Martellaro C, van Doremalen N, Zemtsova G, Self J, Bushmaker T, McNally K, Rowe T, Emery SL, Feldmann F, Williamson BN, Best SM, Nyenswah TG, Grolla A, Strong JE, Kobinger G, Bolay FK, Zoon KC, Stassijns J, Giuliani R, de Smet M, Nichol ST, Fields B, Sprecher A, Massaquoi M, Feldmann H, de Wit E.

Clin Infect Dis. 2016 Oct 15;63(8):1026-33. doi: 10.1093/cid/ciw452. Epub 2016 Aug 15.

36.

Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.

Marzi A, Hanley PW, Haddock E, Martellaro C, Kobinger G, Feldmann H.

J Infect Dis. 2016 Oct 15;214(suppl 3):S360-S366. Epub 2016 Aug 5.

37.

Clinical Chemistry of Patients With Ebola in Monrovia, Liberia.

de Wit E, Kramer S, Prescott J, Rosenke K, Falzarano D, Marzi A, Fischer RJ, Safronetz D, Hoenen T, Groseth A, van Doremalen N, Bushmaker T, McNally KL, Feldmann F, Williamson BN, Best SM, Ebihara H, Damiani IA, Adamson B, Zoon KC, Nyenswah TG, Bolay FK, Massaquoi M, Sprecher A, Feldmann H, Munster VJ.

J Infect Dis. 2016 Oct 15;214(suppl 3):S303-S307. Epub 2016 Jul 28.

38.

Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses.

Yoshida R, Muramatsu S, Akita H, Saito Y, Kuwahara M, Kato D, Changula K, Miyamoto H, Kajihara M, Manzoor R, Furuyama W, Marzi A, Feldmann H, Mweene A, Masumu J, Kapeteshi J, Muyembe-Tamfum JJ, Takada A.

J Infect Dis. 2016 Oct 15;214(suppl 3):S185-S191. Epub 2016 Jul 26.

39.

Inactivation of RNA Viruses by Gamma Irradiation: A Study on Mitigating Factors.

Hume AJ, Ames J, Rennick LJ, Duprex WP, Marzi A, Tonkiss J, Mühlberger E.

Viruses. 2016 Jul 22;8(7). pii: E204. doi: 10.3390/v8070204.

40.

Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015.

de Wit E, Rosenke K, Fischer RJ, Marzi A, Prescott J, Bushmaker T, van Doremalen N, Emery SL, Falzarano D, Feldmann F, Groseth A, Hoenen T, Juma B, McNally KL, Ochieng M, Omballa V, Onyango CO, Owuor C, Rowe T, Safronetz D, Self J, Williamson BN, Zemtsova G, Grolla A, Kobinger G, Rayfield M, Ströher U, Strong JE, Best SM, Ebihara H, Zoon KC, Nichol ST, Nyenswah TG, Bolay FK, Massaquoi M, Feldmann H, Fields B.

J Infect Dis. 2016 Oct 15;214(suppl 3):S169-S176. Epub 2016 Jun 21.

41.

Ebola virus vaccines - reality or fiction?

Mire CE, Geisbert TW, Feldmann H, Marzi A.

Expert Rev Vaccines. 2016 Nov;15(11):1421-1430. Epub 2016 May 9. Review.

42.

The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent.

Hoffmann M, González Hernández M, Berger E, Marzi A, Pöhlmann S.

PLoS One. 2016 Feb 22;11(2):e0149651. doi: 10.1371/journal.pone.0149651. eCollection 2016.

43.

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection.

Marzi A, Murphy AA, Feldmann F, Parkins CJ, Haddock E, Hanley PW, Emery MJ, Engelmann F, Messaoudi I, Feldmann H, Jarvis MA.

Sci Rep. 2016 Feb 15;6:21674. doi: 10.1038/srep21674.

44.

Discovery of an antibody for pan-ebolavirus therapy.

Furuyama W, Marzi A, Nanbo A, Haddock E, Maruyama J, Miyamoto H, Igarashi M, Yoshida R, Noyori O, Feldmann H, Takada A.

Sci Rep. 2016 Feb 10;6:20514. doi: 10.1038/srep20514.

45.

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak.

de Wit E, Falzarano D, Onyango C, Rosenke K, Marzi A, Ochieng M, Juma B, Fischer RJ, Prescott JB, Safronetz D, Omballa V, Owuor C, Hoenen T, Groseth A, van Doremalen N, Zemtsova G, Self J, Bushmaker T, McNally K, Rowe T, Emery SL, Feldmann F, Williamson B, Nyenswah TG, Grolla A, Strong JE, Kobinger G, Stroeher U, Rayfield M, Bolay FK, Zoon KC, Stassijns J, Tampellini L, de Smet M, Nichol ST, Fields B, Sprecher A, Feldmann H, Massaquoi M, Munster VJ.

Emerg Infect Dis. 2016 Feb;22(2):323-6. doi: 10.3201/eid2202.151656.

46.

Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool.

Hoenen T, Groseth A, Rosenke K, Fischer RJ, Hoenen A, Judson SD, Martellaro C, Falzarano D, Marzi A, Squires RB, Wollenberg KR, de Wit E, Prescott J, Safronetz D, van Doremalen N, Bushmaker T, Feldmann F, McNally K, Bolay FK, Fields B, Sealy T, Rayfield M, Nichol ST, Zoon KC, Massaquoi M, Munster VJ, Feldmann H.

Emerg Infect Dis. 2016 Feb;22(2):331-4. doi: 10.3201/eid2202.151796.

47.

Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.

Marzi A, Feldmann F, Hanley PW, Scott DP, Günther S, Feldmann H.

Emerg Infect Dis. 2015 Oct;21(10):1777-83. doi: 10.3201/eid2110.150259.

48.

EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.

Marzi A, Robertson SJ, Haddock E, Feldmann F, Hanley PW, Scott DP, Strong JE, Kobinger G, Best SM, Feldmann H.

Science. 2015 Aug 14;349(6249):739-42. doi: 10.1126/science.aab3920. Epub 2015 Aug 6.

49.

Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target.

Regazzoli D, Ancona F, Trevisi N, Guarracini F, Radinovic A, Oppizzi M, Agricola E, Marzi A, Sora NC, Della Bella P, Mazzone P.

Biomed Res Int. 2015;2015:205013. doi: 10.1155/2015/205013. Epub 2015 Jul 7. Review.

50.

Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection.

Hill-Batorski L, Halfmann P, Marzi A, Lopes TJ, Neumann G, Feldmann H, Kawaoka Y.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S329-35. doi: 10.1093/infdis/jiv335. Epub 2015 Jul 23.

Supplemental Content

Support Center